According to IMS Health, the Singulair granules had sales of nearly $61m in the US market for recent twelve months ending July 2012.
The company has released the 4mg granules in unit dosage package of 30.
Dr. Reddy’s Laboratories offers its service in the pharma field through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products.